Ibrutinib-associated hematoma and ecchymosis in a patient with basal cell carcinoma who underwent Mohs micrographic surgery
Journal Title: Turkderm-Turkish Archives of Dermatology and Venereology - Year 2020, Vol 54, Issue 2
Abstract
Basal cell carcinoma (BCC) is the most common skin cancer. The gold standard therapy is surgery in the treatment of BCC. The recomended surgical method is Mohs micrographic surgery, as it provides the highest cure rates in high-risk BCC in terms of recurrence. It is well known that certain drugs such as aspirin, warfarin and clopidogrel cause bleeding complications during dermatologic surgery. In contrast, it is not well known to have bleeding side effects similar to these drugs. Herein, we present ibrutinib-associated hematoma and ecchymosis in a patient with BCC who underwent Mohs micrographic surgery.
Authors and Affiliations
Sema Koç Yıldırım, Gonca Elçin, Serdar Özer, Özay Gököz
The correlation of age, gender and drug dose with side effects of isotretinoin in patients with acne vulgaris
Background and Design: Acne vulgaris is a chronic inflammatory disease of pilosebaceous unit. Oral isotretinoin is the most effective agent that has been used for many years in acne treatment. The purpose of our study wa...
A challenging diagnosis on dermoscopy: Lichen Planus Pigmentosus
No summary
Does counseling have an effect on sun protection behaviors and early detection of skin cancer in middle-aged and older Turkish people?
Background and Design: The most important avoidable risk factor for skin cancer is ultraviolet light exposure. The aim of this study is to evaluate the frequency and the effect of counseling on sun protection behaviors a...
A case of reactive perforating collagenosis accompanied by scabies and diabetes
Reactive perforating collagenosis (RPC) is characterized by hyperkeratotic papules and histopathologically transepidermal elimination of structural altered collagen fibers. It is often associated with diabetes mellitus a...
Successful treatment of Mycobacterium chelonae skin infection in a patient on long-term immunosuppressive therapy for myasthenia gravis
No summary